NGL Fine Chem Ltd
NSE: NGLFINE BSE: 524774
₹2901.30
(0.81%)
Tue, 13 Oct 2026, 11:21 pm
Market Cap (in Cr)1807.47
PE Ratio31.34
Dividend0.06
Health Technology
Pharmaceuticals: Major
24.5KNGL Fine Chem Cashflow
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deprecation and amortization | -7.62M | -7.76M | -9.36M | -13.53M | -19.33M | -23.20M | -25.97M | -27.22M | -30.79M | -45.61M | -63.00M | -81.12M | -83.34M | -103.69M | -112.91M | -116.42M | -124.51M |
| Accumulated depreciation, total | -34.21M | -34.08M | -43.07M | -56.37M | -75.35M | -98.14M | -110.76M | -130.51M | -29.54M | -70.66M | -128.31M | -236.71M | -315.90M | -400.81M | -506.48M | -616.19M | -733.03M |
| Cash from operating activities | -2.99M | 14.71M | 40.24M | 15.25M | 551.29K | 1.60M | 92.95M | 96.12M | 94.09M | 210.11M | 67.38M | 184.63M | 257.16M | 128.06M | 349.62M | 201.90M | 343.18M |
| Funds from operations | 24.44M | 34.90M | 33.42M | 24.67M | 49.30M | 68.49M | 113.30M | 141.58M | 171.00M | 167.24M | 258.86M | 184.97M | 598.08M | 602.10M | 317.04M | 528.06M | 333.35M |
| Net income (cash flow) | 19.60M | 27.04M | 24.16M | 10.47M | 29.09M | 45.28M | 83.30M | 113.98M | 148.86M | 125.93M | 201.27M | 83.35M | 567.19M | 498.97M | 204.96M | 413.17M | 211.24M |
| Depreciation & amortization (cash flow) | 7.62M | 7.76M | 9.33M | 13.53M | 19.33M | 23.20M | 25.97M | 27.22M | 30.79M | 45.61M | 63.00M | 81.12M | 83.34M | 103.69M | 112.91M | 116.42M | 124.51M |
| Depreciation/depletion | 7.62M | 7.76M | 9.33M | 13.53M | 19.33M | 22.79M | 24.73M | 25.70M | 29.54M | 44.72M | 62.15M | 80.14M | 82.19M | 102.09M | 111.36M | 115.45M | 123.25M |
| Amortization | 0 | 0 | 0 | 0 | — | 408.58K | 1.24M | 1.53M | 1.26M | 887.98K | 854.65K | 981.29K | 1.15M | 1.60M | 1.56M | 968.00K | 1.26M |
| Deferred taxes (cash flow) | — | — | 0 | 0 | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | -14.65M | -12.22M | -14.39M | -4.49M | -14.48M | -21.80M | -41.26M | -64.33M | -87.94M | -56.40M | -79.81M | -16.88M | -261.16M | -167.55M | -69.50M | -132.53M | -68.30M |
| Changes in working capital | -27.43M | -20.18M | 6.82M | -9.42M | -48.74M | -66.88M | -20.35M | -45.46M | -76.90M | 42.87M | -191.47M | -332.26K | -340.91M | -474.04M | 32.59M | -326.16M | 9.83M |
| Cash from investing activities | -11.50M | -22.75M | -56.62M | -46.17M | -30.64M | -36.38M | -27.18M | -99.55M | -172.57M | -229.63M | -71.28M | -184.62M | -109.68M | -290.85M | -303.11M | -285.06M | -737.60M |
| Capital expenditures | -6.95M | -22.21M | -50.08M | -47.27M | -46.14M | -36.38M | -27.46M | -99.60M | -200.79M | -238.60M | -144.98M | -149.16M | -172.12M | -563.76M | -314.07M | -285.24M | -1.31B |
| Capital expenditures - fixed assets | -6.95M | -22.21M | -50.08M | -47.27M | -46.14M | -36.38M | -25.60M | -99.29M | -200.79M | -238.60M | -144.98M | -149.16M | -172.12M | -563.76M | -314.07M | -285.24M | -1.31B |
| Capital expenditures - other assets | 0 | 0 | 0 | 0 | 0 | — | -1.86M | -313.80K | -1.34M | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from financing activities | 16.74M | 7.55M | 14.02M | 30.39M | 37.86M | 30.48M | -37.81M | 16.32M | 76.40M | 32.31M | -3.08M | -3.91M | -130.44M | 148.19M | 25.34M | 8.82M | 396.30M |
| Free cash flow | -9.95M | -7.49M | -9.84M | -32.02M | -45.59M | -34.78M | 67.34M | -3.17M | -106.70M | -28.49M | -77.60M | 35.48M | 85.04M | -435.70M | 35.55M | -83.34M | -964.54M |
